Wnt signalling and prostate cancer
- 5 April 2005
- journal article
- review article
- Published by Springer Science and Business Media LLC in Prostate Cancer and Prostatic Diseases
- Vol. 8 (2), 119-126
- https://doi.org/10.1038/sj.pcan.4500794
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Up‐regulation of Wnt‐1 and β‐catenin production in patients with advanced metastatic prostate carcinomaCancer, 2004
- Cyclin-dependent kinase 2 regulates the interaction of Axin with β-cateninBiochemical and Biophysical Research Communications, 2004
- Crossregulation of NF‐κB by the APC/GSK‐3β/β‐catenin pathwayMolecular Carcinogenesis, 2004
- The Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt PathwayPLoS Biology, 2003
- Synergistic Induction of Tumor Antigens by Wnt-1 Signaling and Retinoic Acid Revealed by Gene Expression ProfilingPublished by Elsevier BV ,2002
- APC/CTNNB1 (β‐catenin) pathway alterations in human prostate cancersGenes, Chromosomes and Cancer, 2002
- Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activationOncogene, 2001
- The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of actionEuropean Journal of Cancer, 2000
- GSK-3β-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by β-catenin and protein phosphatase 2A complexed with AxinOncogene, 2000
- APC mutations occur early during colorectal tumorigenesisNature, 1992